Kymera (KYMR) Jumps to All-Time High as Eczema Treatment Results Impress

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Kymera Therapeutics, Inc. (NASDAQ:KYMR) is one of the best performers on Monday. Kymera Therapeutics soared to a new all-time high on Monday after rallying for four consecutive days, as investor sentiment was boosted by the stellar results of its clinical trial to test the efficacy of KT-621 in patients with moderate to severe eczema. At intra-day trading, the stock soared to its highest price of $103 before trimming gain ...